The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Serum protein markers for early detection of ovarian cancer
Open accessAbstract
Early diagnosis of epithelial ovarian cancer (EOC) would significantly decrease the morbidity and mortality from this disease but is difficult in the absence of physical symptoms. Here, we report a blood test, based on the simultaneous quantization of four analytes (leptin, prolactin, osteopontin, and insulin-like growth factor-II), that can discriminate between disease-free and EOC patients, including patients diagnosed with stage I and II disease, with high efficiency (95%). Microarray analysis was used initially to determine the levels of 169 proteins in serum from 28 healthy women, 18 women newly diagnosed with EOC, and 40 women with recurrent disease. Evaluation of proteins that showed significant differences in expression between controls and cancer patients by ELISA assays yielded the four analytes. These four proteins then were evaluated in a blind cross-validation study by using an additional 106 healthy females and 100 patients with EOC (24 stage I/II and 76 stage III/IV). Upon sample decoding, the results were analyzed by using three different classification algorithms and a binary code methodology. The four-analyte test was further validated in a blind binary code study by using 40 additional serum samples from normal and EOC cancer patients. No single protein could completely distinguish the cancer group from the healthy controls. However, the combination of the four analytes exhibited the following: sensitivity 95%, positive predictive value (PPV) 95%, specificity 95%, and negative predictive value (NPV) 94%, a considerable improvement on current methodology.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Elements of Statistical Learning
Hastie, T., Friedman, J., & Tibshirani, R. (2001) · Springer Series in Statistics · doi:10.1007/978-0-387-21606-5 · Cited by 24,162
Jemal, A., Murray, T., Ward, E., Samuels, A., Tiwari, R. C., Ghafoor, A., Feuer, E. J., & Thun, M. J. (2005) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.55.1.10 · Cited by 4,186
Use of proteomic patterns in serum to identify ovarian cancer
Petricoin, E. F., Ardekani, A. M., Hitt, B. A., Levine, P. J., Fusaro, V. A., Steinberg, S. M., Mills, G. B., Simone, C., Fishman, D. A., Kohn, E. C., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)07746-2 · Cited by 3,236
Zhang, Z., Bast, R. C., Yu, Y., Li, J., Sokoll, L. J., Rai, A. J., Rosenzweig, J. M., Cameron, B., Wang, Y. Y., Meng, X.-Y., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0746 · Cited by 934
Multiplexed protein profiling on microarrays by rolling-circle amplification
Schweitzer, B., Roberts, S., Grimwade, B., Shao, W., Wang, M., Fu, Q., Shu, Q., Laroche, I., Zhou, Z., Tchernev, V. T., et al. (2002) · Nature Biotechnology · doi:10.1038/nbt0402-359 · Cited by 573
Osteopontin as a Potential Diagnostic Biomarker for Ovarian Cancer
Kim, J.-H. (2002) · JAMA · doi:10.1001/jama.287.13.1671 · Cited by 480
Progress and Challenges in Screening for Early Detection of Ovarian Cancer
Jacobs, I. J., & Menon, U. (2004) · Molecular & Cellular Proteomics · doi:10.1074/mcp.r400006-mcp200 · Cited by 458
Lu, K. H., Patterson, A. P., Wang, L., Marquez, R. T., Atkinson, E. N., Baggerly, K. A., Ramoth, L. R., Rosen, D. G., Liu, J., Hellstrom, I., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0409 · Cited by 440
Schwartz, D. R., Kardia, S. L. R., Shedden, K., Kuick, R. D., Michailidis, G. C., Taylor, J. M. G., Misek, D. E., WU, R. T., Zhai, Y., Darrah, D. M., et al. (2002) · PubMed · Cited by 430
Elevated serum bone sialoprotein and osteopontin in colon, breast, prostate, and lung cancer.
Fedarko, N. S., Jain, A., Karadağ, A., Eman, M. R. V., & Fisher, L. W. (2001) · PubMed · Cited by 380
Protein arrays and microarrays
Zhu, H., & Snyder, M. (2001) · Current Opinion in Chemical Biology · doi:10.1016/s1367-5931(00)00170-8 · Cited by 353
Kozak, K. R., Amneus, M. W., Pusey, S. M., Su, F., Luong, M. N., Luong, S. A., Reddy, S. T., & Farias-Eisner, R. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2033602100 · Cited by 276
Mantovani, G., Macciò, A., Mura, L., Massa, E., Mudu, M. C., Mulas, C., Lusso, M. R., Madeddu, C., & Dessì, A. (2000) · Journal of Molecular Medicine · doi:10.1007/s001090000137 · Cited by 232
Plasma Prolactin Concentrations and Risk of Postmenopausal Breast Cancer
Tworoger, S. S., Eliassen, A. H., Rosner, B., Sluss, P., & Hankinson, S. E. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1870 · Cited by 210
Evaluation of Osteopontin as Biomarker for Pancreatic Adenocarcinoma
Koopmann, J., Fedarko, N. S., Jain, A., Maitra, A., Iacobuzio-Donahue, C., Rahman, A., Hruban, R. H., Yeo, C. J., & Goggins, M. (2004) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.487.13.3 · Cited by 195
Combining CA 125 and SMR serum markers for diagnosis and early detection of ovarian carcinoma
McIntosh, M. W., Drescher, C., Karlan, B., Scholler, N., Urban, N., Hellstrom, K. E., & Hellstrom, I. (2004) · Gynecologic Oncology · doi:10.1016/j.ygyno.2004.07.039 · Cited by 193
Plasma leptin and colorectal cancer risk: A prospective study in Northern Sweden
Stattin, P., Palmqvist, R., Söderberg, S., Biessy, C., Ardnor, B., Hallmans, G., Kaaks, R., & Olsson, T. (2003) · Oncology Reports · doi:10.3892/or.10.6.2015 · Cited by 178
Skates, S. J., Horick, N., Yu, Y., Xu, F.-J., Berchuck, A., Havrilesky, L. J., de Bruijn, H. W. A., van der Zee, A. G. J., Woolas, R. P., Jacobs, I. J., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.03.091 · Cited by 170
Osteopontin as an Adjunct to CA125 in Detecting Recurrent Ovarian Cancer
Schorge, J. O., Drake, R. D., Lee, H., Skates, S. J., Rajanbabu, R., Miller, D. S., Kim, J., Cramer, D. W., Berkowitz, R. S., & Mok, S. C. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0365 · Cited by 108
Plasma Leptin and Breast Cancer Risk: A Prospective Study in Northern Sweden
Stattin, P. E., Söderberg, S., Olsson, T., Hallmans, G., Lenner, P., Biessy, C., & Kaaks, R. (2004) · Breast Cancer Research and Treatment · doi:10.1023/b:brea.0000036782.11945.d7 · Cited by 96
Standal, T., Hjorth‐Hansen, H., Rasmussen, T., Dahl, I. M. S., Lenhoff, S., Brenne, A., Seidel, C., Baykov, V., Waage, A., Børset, M., et al. (2004) · PubMed · Cited by 82
Generating longitudinal screening algorithms using novel biomarkers for disease.
McIntosh, M. W., Urban, N. D., & Karlan, B. Y. (2002) · PubMed · Cited by 60
Serum levels of leptin and proinflammatory cytokines in patients with gastrointestinal cancer
Dülger, H., Alıcı, S., ekeroǦlu, M. R. Ş., Erkog, R., Özbek, H., Noyan, T., & Yavuz, M. (2004) · International Journal of Clinical Practice · doi:10.1111/j.1368-5031.2004.00149.x · Cited by 46
Ribeiro, R. J. T., Lopes, C., & Medeiros, R. (2004) · European Journal of Cancer Prevention · doi:10.1097/00008469-200410000-00002 · Cited by 45
Importance of serum prolactin determination in metastatic breast cancer patients.
Mujagić, Z., & Mujagić, H. (2004) · PubMed · Cited by 40
Cited by
Protein biomarker discovery and validation: the long and uncertain path to clinical utility
Rifai, N., Gillette, M. A., & Carr, S. A. (2006) · Nature Biotechnology · doi:10.1038/nbt1235 · Cited by 1,867
Assarsson, E., Lundberg, M., Holmquist, G., Björkesten, J., Bucht Thorsen, S., Ekman, D., Eriksson, A., Rennel Dickens, E., Ohlsson, S., Edfeldt, G., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0095192 · Cited by 1,874
The tumour-induced systemic environment as a critical regulator of cancer progression and metastasis
McAllister, S. S., & Weinberg, R. A. (2014) · Nature Cell Biology · doi:10.1038/ncb3015 · Cited by 966
Multiplexed protein measurement: technologies and applications of protein and antibody arrays
Kingsmore, S. F. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2006 · Cited by 715
Systemic Endocrine Instigation of Indolent Tumor Growth Requires Osteopontin
McAllister, S. S., Gifford, A. M., Greiner, A. L., Kelleher, S. P., Saelzler, M. P., Ince, T. A., Reinhardt, F., Harris, L. N., Hylander, B. L., Repasky, E. A., et al. (2008) · Cell · doi:10.1016/j.cell.2008.04.045 · Cited by 431
Metadata
- Authors
- Mor, G., Visintin, I., Lai, Y., Zhao, H., Schwartz, P., Rutherford, T., Yue, L., Bray-Ward, P., & Ward, D. C.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2005-05-12
- Volume
- 102
- Issue
- 21
- Pages
- 7677-7682
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2072347219
- Cited by
- 482
- References
- 25
- FWCI
- 35.38
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.